Cell Cybernetics
Menu
Close
News
Announcements
Select year
Jan 26 2023
Placing to Raise £4,056,250
Read
Jan 23 2023
HEMO-CAR-T Third Process Qualification Run Completed
Read
Jan 9 2023
Single CBR Can Treat Multiple Viruses
Read
Jan 4 2023
HEMO-CAR-T Second Process Qualification Run Completed
Read
Dec 13 2022
HEMO-CAR-T First Process Qualification Run Completed
Read
Nov 18 2022
HEMO-CAR-T Process Development Runs Completed
Read
Sep 29 2022
Half-year Report – Interim Results for the Period Ended 30 June 2022
Read
Sep 1 2022
Presentation at H.C. Wainwright Global Investment Conference
Read
Aug 22 2022
Appointment of Director of Quality
Read
Aug 15 2022
Approval and Issuance of Chinese Bi-specific Antibody Patent
Read
Load more
Cell CyberneticsCell Cybernetics